Trial Profile
An observational, longitudinal study evaluating safety of rLP2086 in a college-age population in a real-world setting.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Dec 2016
Price :
$35
*
At a glance
- Drugs PF 5212366 (Primary)
- Indications Meningococcal infections
- Focus Adverse reactions
- 30 Dec 2016 New trial record